Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 214-300-6 | CAS number: 1120-21-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
Acute Toxicity-Oral LD50 > 5000 mg/kg in rats (OECD TG 401)
Acute Toxicity-Inhalation LC50 > 2825.69 mg/m3 (maximum attainable vapour concentration of n-C11) (OECD TG 403)
Acute Toxicity-Dermal LD50 > 3160 mg/kg in rabbits (OECD TG 402)
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- From November 14, 1994 To January 5, 1995
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: According to or similar to OECD guideline 401: GLP.
- Justification for type of information:
- A discussion and report on the read across strategy is given as an attachment in IUCLID Section 13.
- Reason / purpose for cross-reference:
- read-across: supporting information
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Taconic Farms
- Age at study initiation: Approximately 10-11 weeks
- Weight at study initiation: 195 to 282 grams
- Housing: 5 per cage
- Diet (e.g. ad libitum): ad libitum, Purina Rodent Chow
- Water (e.g. ad libitum):ad libitum
- Acclimation period:21days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): maintained range 20-24.4
- Humidity (%): maintained range 40-70
- Photoperiod (hrs dark / hrs light): 12hrs dark / 12 hrs light - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- Undiluted test material was administered by a single oral intubation via syringe and a No. 13 ball tipped feeding needle.
- Doses:
- 5000mg/kg
- No. of animals per sex per dose:
- 10 animals per dose (5 male; 5 female)
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations were made as to the nature, onset, severity, and duration of toxicological signs at 1, 2, 4, and 6 hours after dosing, and once per day thereafter for a total of 14 Days. Body weights were recorded on the day prior to dosing (pretest), the day of dosing (Day 0), on Day 7, and on Day 14, and at death for those which succumbed.
- Necropsy of survivors performed: yes - Statistics:
- The means and standard deviations of the body weights and body weight changes, by sex and group were calculated .
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Mortality:
- 5000 mg/kg: 0 males; 0 females
- Clinical signs:
- other: Ano-genital staining, observed at the 6 hour interval, was the only remarkable clinical in-life observation.
- Gross pathology:
- All animals were free of abnormalities at postmortem examination.
- Interpretation of results:
- other: Not classified
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral LD50 for MRD-83-205 is >5000 mg/kg. Classification as an oral toxicant is not warranted under the new Regulation (EC) 1272/2008 on classification, labeling and packaging of substances and mixtures (CLP) or under Directive 67/518/EEC for dangerous substances and Directive 1999/45/EC for preparations.
- Executive summary:
MRD-83-205 was administered via oral intubation to 5 male and 5 female rats at a dose of 5000 mg/kg to assess acute oral toxicity. Animals were observed daily for 14 days post dosing. No overt signs of toxicity were apparent. All animals survived to study termination. All animals were free of abnormalities at postmortem examination. All surviving animals displayed increases in body weight over their day 0 values. The acute oral LD50 for MRD-83-205 is >5000 mg/kg. Classification as an oral toxicant is not warranted under the new Regulation (EC) 1272/2008 on classification, labeling and packaging of substances and mixtures (CLP) or under Directive 67/518/EEC for dangerous substances and Directive 1999/45/EC for preparations.
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 1988/5/10 - 1988/5/24
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: According to OECD test guideline 401. GLP.
- Justification for type of information:
- A discussion and report on the read across strategy is given as an attachment in IUCLID Section 13.
- Reason / purpose for cross-reference:
- read-across: supporting information
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Kleintierfarm Madoerin AG
- Age at study initiation: 9 weeks
- Weight at study initiation: males: 179-197g, females: 162-180g
- Fasting period before study: 12-18h
- Housing: individually
- Diet (e.g. ad libitum): Pelleted standard Kliba 343, batch 95/88 rat maintenance diet, ad libitum
- Water (e.g. ad libitum): community tap water from Itingen, ad libitum
- Acclimation period: at least one week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3
- Humidity (%): 40-70%
- Photoperiod (hrs dark / hrs light): 12
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: undiluted, as delivered by sponsor
- Amount of vehicle (if gavage): 5000 mg/kg
- Justification: the oral administration was used, because this is one possible route of human exposure during manufacture, handling and use of the test article - Doses:
- 5000 mg per kg bodyweight
- No. of animals per sex per dose:
- 5 males and 5 females (one dose)
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 15 days
- Frequency of observations and weighing: observations were made as to the nature, onset, severity, and duration of toxicological signs 4 times during day one, and once per day during day 2-15. Body weights were recorded on the test day prior to dosing and on Day 8 and Day 15, and at death for those which succumbed.
- Necropsy of survivors performed: yes - Statistics:
- The LOGIT-model could not be applied to the observed rates of death. The toxicity was estimated without use of a statistical model.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Mortality:
- No mortality
- Clinical signs:
- other: 5000 mg/kg: sedation, dyspnea, hunched posture, ruffled fur All animals had recovered until day 5 of the observation
- Gross pathology:
- All animals were free of abnormalities at postmortem examination.
- Interpretation of results:
- other: Not classified
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral LD50 for the test material is >5000 mg/kg. Classification as an oral toxicant is not warranted under the new Regulation (EC) 1272/2008 on classification, labeling and packaging of substances and mixtures (CLP) or under Directive 67/518/EEC for dangerous substances and Directive 1999/45/EC for preparations.
- Executive summary:
C9 -C11 cyclic aliphatics were administered via oral gavage to 5 male and 5 female rats at a dose of 5000 mg/kg to assess acute oral toxicity. Animals were observed daily for 15 days post dosing. At a dose of 5000 mg/kg, signs of toxicity were sedation, dyspnea, hunched posture and ruffled fur. All animals had recovered until day 5 of observation and survived to study termination. All animals were free of abnormalities at postmortem examination. All surviving animals displayed increases in body weight over their day 0 values. The acute oral LD50 for C9 -C11 cyclic aliphatics is >5000 mg/kg. Classification as an oral toxicant is not warranted under the new Regulation (EC) 1272/2008 on classification, labeling and packaging of substances and mixtures (CLP) or under Directive 67/518/EEC for dangerous substances and Directive 1999/45/EC for preparations.
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 1977
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable well-documented study report which meets basic scientific principles: non-GLP
- Justification for type of information:
- A discussion and report on the read across strategy is given as an attachment in IUCLID Section 13.
- Reason / purpose for cross-reference:
- read-across: supporting information
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- yes
- Remarks:
- only one dose tested
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Sex: Males (5); Females (5)
- Weight at study initiation: Males (190-195 g), Females (194-205 g)
- Housing: individual - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- A single dose of MRD-77-10 (15 g/kg) was administered by oral gavage.
- Doses:
- 15 g/kg
- No. of animals per sex per dose:
- Male (5), Female (5)
- Control animals:
- no
- Details on study design:
- The acute oral toxicity of MRD-77-10 was investigated in a group of 5 male and 5 female rats. Each animal received a single oral dose of 15 g/kg administered by oral gavage. The condition of all animals was observed over a 14 day period following dosing.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 15 000 mg/kg bw
- Mortality:
- No mortality was observed in any of the animals treated with 15 g/kg MRD-77-10.
- Clinical signs:
- other: Hair loss of the urogenital region was noted in 4 males/5 females. Kidneys appeared darker then normal in 2 males and 3 females, but no pathology was noted. All animals gained weight through out the observational period.
- Gross pathology:
- Kidneys appeared darker then normal in 2 males and 3 females, but no pathology was noted.
- Interpretation of results:
- other: Not classified
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The LD50 for MRD-77-10 following oral gavage was >15 g/kg . Classification as an oral toxicant is not warranted under the new Regulation (EC) 1272/2008 on classification, labeling and packaging of substances and mixtures (CLP) or under Directive 67/518/EEC for dangerous substances and Directive 1999/45/EC for preparations.
- Executive summary:
The acute toxicity of MRD-77-10 was evaluated in rats via oral gavage at a dose of 15 g/kg bw. Observations were made as to the nature, onset, severity, and duration of toxicological signs once per day for a total of 14 days. All animals survived the entire observational period and displayed a low incidence of clinical symptoms. The LD50 for MRD-77-10 following oral gavage was >15 g/kg. Classification as an oral toxicant is not warranted under the new Regulation (EC) 1272/2008 on classification, labeling and packaging of substances and mixtures (CLP) or under Directive 67/518/EEC for dangerous substances and Directive 1999/45/EC for preparations.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- Three key read across studies available from structural analogues.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 1995
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well-documented study report equivalent or similar to OECD guideline 403 : GLP.
- Justification for type of information:
- A discussion and report on the read across strategy is given as an attachment in IUCLID Section 13.
- Reason / purpose for cross-reference:
- read-across: supporting information
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River
- Age at study initiation: 9-11 weeks
- Weight at study initiation: 245-325 g
- Housing:individually
- Diet (e.g. ad libitum): ad libitum during non-exposure, food withheld while in chamber
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 14 days
ENVIRONMENTAL CONDITIONS
- Temperature (°F): 68-76
- Humidity (%): 40-70
- Photoperiod (hrs dark / hrs light): 12/12
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
Exposure apparatus: 150 liter stainless steel inhalation chamber
- Exposure chamber volume: 150 liter
- Temperature, humidity, pressure in air chamber: 75° F, 48%, slight negative pressure to the room
TEST ATMOSPHERE
- Brief description of analytical method used: calibrated infrared monitor
- Samples taken from breathing zone: no
CLASS METHOD (if applicable)
- Rationale for the selection of the starting concentration: - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- actual vapor concentration of6100 mg/m3
- No. of animals per sex per dose:
- 10 animals/dose (5 males; 5 females)
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Day 0, 7, and 14
- Necropsy of survivors performed: yes - Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- >= 6 100 mg/m³ air (analytical)
- Exp. duration:
- 4 h
- Mortality:
- None
- Clinical signs:
- other: None
- Body weight:
- Body weight appeared normal throughout experiment. One female lost 2 grams during the Day 7-14 post-exposure observation period.
- Gross pathology:
- All animals appeared normal.
- Other findings:
- N/A
- Interpretation of results:
- other: Not classified
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The LC50 for acute inhalation exposure to MRD-94-979 vapor is greater than 6100 mg/m3. Classification as an acute inhalation toxicant is not warranted under the new Regulation (EC) 1272/2008 on classification, labeling and packaging of substances and mixtures (CLP) or under Directive 67/518/EEC for dangerous substances and Directive 1999/45/EC for preparations.
- Executive summary:
MRD-94-979 was administered via individual inhalation chambers for four hours to ten Sprague-Dawley rats (5 males, 5 females) to an average actual vapor concentration of 6100 mg/m3 for four hours to assess acute inhalation toxicity. Animals were observed for fourteen days following exposure. There were no mortality or gross pathological alterations noted in any of the animals. Based on the conditions of this study, The LC50 for acute inhalation exposure to MRD-94-979 vapor is greater than 6100 mg/m3. Classification as an acute inhalation toxicant is not warranted under the new Regulation (EC) 1272/2008 on classification, labeling and packaging of substances and mixtures (CLP) or under Directive 67/518/EEC for dangerous substances and Directive 1999/45/EC for preparations.
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 1988
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: According to or similar to guideline study OECD 403.
- Justification for type of information:
- A discussion and report on the read across strategy is given as an attachment in IUCLID Section 13.
- Reason / purpose for cross-reference:
- read-across: supporting information
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- yes
- Remarks:
- 8 hour exposure
- GLP compliance:
- not specified
- Test type:
- acute toxic class method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Male Sprague-Dawley rats were obtained from Mollegaard A/S. The animals were acclimatized for 4 to 6 days prior to exposure at a temperature of 22 +/-1 oC, a humidity of 40-70% and a dark-light cycle of 12 hours. The same conditions were used during exposure. Food and water was given ad libitum, except during exposure. At exposure, the weights of animals were within the range of 200g +/- 20%.
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- Exposure system. During exposure the animals were kept in conically shaped 0.7 m3 steel chambers with glass front door and walls. Dynamic exposure was performed by passing high oil- and dust- filtered air under pressure through 4 reservoirs of each containing 0.5 1 of the test alkane. At an air flow rate of 30-441 L/min, an outlet concentration equal to 95% of vapour saturation was achieved. The vapour generating system was located in a water bath with a temperature control unit allowing a range of temperature from 0 to 50. Saturation concentrations of alkanes at 2W were achieved by keeping a constant temperature in the bath of 21.6, slightly lower than the temperature in the inhalation chamber. At one occasion (n-nonane, 5280 ppm.) vapour was generated at 22.5°. Air from the vapour generating system was introduced at the top of the exposure chamber and drained from the chamber through a perforated bottom outlet.
Air was withdrawn from the inhalation chambers by a ventilation fan creating a negative pressure of 2-5 mm H20 on the inside of the chamber. During exposure the flow of air through the chambers (exposure and control) was 30-40 L/mm., corresponding approximately to 3 air changes per hour. With a maximum number of 18 animal in each chamber, the volume of animals represented about 0.5% of the total chamber volume. This is a small volume compared to the maximum limit of 5% recommended by WHO. With a volume ratio of 0.5%, 3 air changes per hour was sufficient in order to prevent significant concentrations of ammonia in the inhaled air. The presence of alkane aerosol in the inhalation chamber during exposure was investigated by a Royco mod. 225 particle monitor with an aerosol particle counter sensor mod. For n-tridecane (nC13) the number of aerosol particles in the air with a diameter greater than 0.3 pm was less than 460 per liter. Assuming a mean particle size of 0.7 um, the aerosol n-tridecane concentration in the air would be 1.24 x 10^-7 mg/L. The measured concentration of n-tridecane vapour at saturation was 0.38 mg/L (50 p.p.m.), giving a vapour/aerosol ratio of 3.04 x 10^6. - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- Concentration of alkanes in the inhalation chambers was monitored automatically every 15 min by on-line gas chromatography.
- Duration of exposure:
- 8 h
- Concentrations:
- n-C9 (n-nonane): 5280, 4438, 3560, 2414 ppm
n-C10 (n-decane): 1369 ppm (saturation)
n-C11 (n-undecane): 442 ppm (saturation)
n-C12 (n-dodecane): 142 (saturation)
n-C13 (n-tridecane): 41 ppm (saturation) - No. of animals per sex per dose:
- 8 animals for each substance at each dose
- Control animals:
- yes
- Details on study design:
- The inhalation period was 8 hours at daytime during the light period for all alkanes followed by an observation period of 14 days. For each alkane a high level exposure was performed at its maximum concentration in the air at 20 deg C, i.e. saturated vapour. When this exposure proved lethal, additional exposures were performed in order to determine an exact LC50 value. During inhalation all animals were observed at 15 and 30 mm. intervals. For the first 8 hours after exposure all animals were observed at hourly, then at 2 hours’ intervals during daytime for 14 consecutive days. Groups of 8 animals were exposed for determination of alkane concentrations in blood and brain. Control groups of 4 animals were exposed simultaneously but only to air under otherwise identical conditions. Measurements were performed in 5 surviving animals from the exposed group and in 4 control animals. Groups of 10 animals were included in the pathological study. All were subjected to a complete necropsy which included examination of the external surface of the body, all orifices, and the cranial, thoracic and abdominal cavities and their contents according to the OECD procedures (OECD 1987). Animals dying during exposure to the saturated air concentration of alkanes at 20 deg C were immediately examined by autopsy, while animals surviving this concentration were killed and examined after the observation period of 14 days. A maximum of 5 exposed animals were investigated for each alkane except for the n-nonane exposure where all 10 animals were examined. The control group for each alkane exposure consisted of 3 rats, giving a total number of 15 control animals.
Determination of alkane concentration in biological material. Concentrations of alkanes were determined in blood and brain via head space gas chromatography immediately after the end of the 8 hour exposure period. Animals were removed from the chamber one by one for immediate decapitation and sample preparation. The preparation of samples was performed after a standardized time schedule with less than two mi between decapitation and isolation of blood and the brain samples from each animal. Immediately after decapitation 2 ml of blood was collected from each animal in heparinized (1,000 IU) glass tubes and rapidly transferred to 15 mln head space vials which were closed by a screw cap with a teflon-faced neoprene septum. After equilibrating the control, “exposed” and standard (0.5—1000 mg/L) samples at 60 for 1 hour during continuous agitation, a 0.1 ml head space sample was taken with a pre-warmed gas-tight syringe and injected onto the gas chromatograph. The gas chromatographic conditions were identical to the conditions described previously for the measurement of alkane concentrations in the inhaled air. After decapitation and blood collection the brain was excised, weighed, and homogenized in 4 volumes of 0.25 M sucrose at 4 in a Potter-Elvehjem homogenizer. Two ml of homogenate was transferred to head space vials and further treated as described above, loss of alkanes during the sampling procedures represented no significant analytical source of error as demonstrated in recovery studies with n-nonane, the most volatile of the test substances.
Determination of LC50. The LC50 value was determined by 8 hour exposure and an observation period of 14 days. Groups of 10 animals were exposed to 4 different concentrations of alkanes, the highest concentration produced close to a 100% mortality. The lowest concentration and two intermediate concentrations reported no cases of death.
Behavioural effects. In addition to general activity, acute effects as coordination difficulties, tremor, spasms and lethality were monitored.
Fixation procedures. For histological examinations the entire brain, both lungs, the liver, the heart and the kidneys were initially fixed for 12 hours in 10% formol ethanol containing 5% glacial acetic acid. Pieces of each organ were then transferred to 70% ethanol and processed for paraffin embedding. Sections were cut with the microtome knife. Sections from each organ were stained in batches with haematoxylin-eosin-saffron.
Light microscopic evaluation. After staining, the slides were given random numbers. Each slide was studied by a group of 4 pathologists working in pairs. One transverse section of the cerebrum, one sagittal section of the cerebellar vermis, one section of each lung and one section of the heart, the liver and the right kidney were evaluated for each animal.
Morphometry. Morphometry was carried out in order to quantify the loss of cerebellar Purkinje cells in the animals exposed to nonane. - Statistics:
- For a detailed description of the morphometrical procedure, see Weibel (1979).
Weibel, E. K.: Stereological methods. Vol. I. Academic Press. London 1979. - Sex:
- male
- Dose descriptor:
- other: NOAEC
- Effect level:
- 2 414 ppm
- Exp. duration:
- 8 h
- Remarks on result:
- other: for all materials tested (n-C9 to n-C13 alkanes)
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- 4 467 ppm
- Exp. duration:
- 8 h
- Remarks on result:
- other: n-nonane
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- > 1 369 ppm
- Exp. duration:
- 8 h
- Remarks on result:
- other: n-decane; maximum attainable concnetration
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- > 442 ppm
- Exp. duration:
- 8 h
- Remarks on result:
- other: n-undecane; maximum attainable concnetration
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- > 142 ppm
- Exp. duration:
- 8 h
- Remarks on result:
- other: n-dodecane; maximum attainable concnetration
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- > 41 ppm
- Exp. duration:
- 8 h
- Remarks on result:
- other: n-tridecane; maximum attainable concnetration
- Mortality:
- No deaths were noted for the maximum vapor concentration for the n-C10 to n-C13 alkanes tested. For n-nonane (n-C9) the following deaths were observed: 5280 ppm - 9/10; 4438 ppm - 4/10; 3560 ppm - 1/10; 2414 ppm - 0/10.
- Clinical signs:
- other: A sedative effect or narcosis was not observed. Neither deaths nor adverse behavioral effects were observed during 8 hours exposure to n-decane n-undecane, n-dodecane, n-tridecane, and n-nonane (2414 ppm). Symptoms such as tremor, spasms and limb paralys
- Body weight:
- There was a significant body weight increase in the 4438 ppm exposed animals. No other body weight changes were noted.
- Gross pathology:
- No significant differences in the weight of the heart, kidneys, liver, or brain were demonstrated between the groups. No morphological alterations were observed in heart or kidneys.
- Other findings:
- Microscopically, dilatation of the sinusoids was found in all four animals dying during exposure to n-nonane and three of these animals also showed definite though slight fatty changes of the liver cells. In animals surviving exposure to n-nonane and in animals exposed to other alkanes, and among the controls, no such changes were observed.
Lungs. The total weight of the lungs in two of the animals dying during exposure to n nonane was approximately twice the weight of the controls 2.86 g and 2.88 g, respectively. Among the other animals exposed to various other alkanes, no weight alterations were observed. Microscopically, three animals showed marked pulmonary edema. These animals died during exposure to n-nonane and in two of them the pulmonary weight was also increased. All animals exposed to 4438 ppm n-nonane showed a blue discoloration of the skin during exposure, giving the impression of peripheral cyanosis, and thus cardiopulmonary insufficiency.
Brain. No macroscopic abnormalities were recorded in any of the animals. No pathological changes were found in the large brain in any of the animals exposed to the series n-Cl0 to n-Cl3 or of their respective controls. In animals exposed to n-nonane (4438 ppm) and which died during exposure, pathological changes were absent. Among the six animals surviving for 14 days after exposure, one animal showed a few severely damaged neurons of the hippocampus. In the cerebellar cortex no alteration could be demonstrated among animals exposed to n-Cl0 to n-C13 or their controls or in animals dying acutely during exposure to n-nonane or their controls. However, in n-nonane (4438 ppm treated group) exposed animals surviving for 14 days after exposure, extensive changes were observed including rarification of Purkinje cells and in some instances also a high number of severely damaged neurons were observed. These changes apparently were not entirely random but seemed to some extent to be segmental. In areas showing massive loss of Purkinje cells there was no obvious glial reaction.
Morphometry of the cerebellum. The results demonstrate clearly a loss of Purkinje cells in the animals which survived exposure to 4438 ppm n-nonane. This is reflected by a reduced density of Purkinje cell profiles along the line which defines the Purkinje cell layer (N0). The reduced density of the visible transections is only in part explained by a reduction of the cell size, as there are also a significantly reduced number of Purkinje cells per unit area of Purkinje cell layer (Ns). The results also indicate a reduction of tissue volume in the other layers of the cerebellum as there was a decrease in cerebellar volume relative to the extent of the Purkinje cell layer. There was no clear-cut change of the volume distribution between the different layers. There was no detectable difference between the animals which died during exposure and the controls. - Interpretation of results:
- other: Not classified
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The LC50 after an 8 hour exposure for acute inhalation exposure to n-C10 to n-C13 alkane vapors is greater than the highest obtainable vapor concentration. The LC50 after an 8 hour exposure for n-C9 alkane vapors was determined to be 4467ppm. For n-C9 to n-C13 alkanes, classification as an acute inhalation toxicant is not warranted under the new Regulation (EC) 1272/2008 on classification, labeling and packaging of substances and mixtures (CLP) or under Directive 67/518/EEC for dangerous substances and Directive 1999/45/EC for preparations.
- Executive summary:
Individual alkanes (n-C9 to n-C13) were administered via individual inhalation chambers to eight Sprague-Dawley rats at their respective maximum attainable vapor concentration (n-C9: 5280, 4438, 3560, 2414 ppm; n-C10: 1369 ppm; n-C11: 442 ppm, n-C12; 142 ppm; n-C13: 41 ppm) for eight hours to assess acute inhalation toxicity. There was no mortality and no gross pathological alterations noted in any of the animals treated with n-C10 to n-C13. The LC50 after an 8 hour exposure for n-C9 alkane vapors was determined to be 4467 ppm. The LC50 after an 8 hour exposure for acute inhalation exposure to n-C10 to n-C13 alkane vapors is greater than the highest obtainable vapor concentration. The LC50 after an 8 hour exposure for n-C9 alkane vapors was determined to be 4467 ppm. For n-C9 to n-C13 alkanes, classification as an acute inhalation toxicant is not warranted under the new Regulation (EC) 1272/2008 on classification, labeling and packaging of substances and mixtures (CLP) or under Directive 67/518/EEC for dangerous substances and Directive 1999/45/EC for preparations.
Referenceopen allclose all
Table 1 | Concentration of alkanes in rat blood and brain at the end of an 8 hour exposure period | ||||
Exposure Conc. (ppm) | Blood concentration (mg/L) | Brain concentration (mg/kg) | Blood/air ratio | Blood/air ratio | |
n-C9 (n-nonane) | 5280 | 238* | 1136* | 8.6 | 41.3 |
4438 | 109 | 919 | 4.7 | 39.5 | |
3560 | 135 | 590 | 7.2 | 31.7 | |
2414 | 57 | 314 | 4.5 | 24.3 | |
n-C10 (n-decane) | 1369 (saturation) | 542 | 239.7 | 6.8 | 29.9 |
n-C11 (n-undecane) | 442 (saturation) | 11.7 | 45.4 | 4.1 | 16 |
n-C12 (n-dodecane) | 142 (saturation) | 3.3 | 4.2 | 3.3 | 4.3 |
n-C13 (n-tridecane) | 41 (saturation) | 0.84 | < 0.5 | 1.6 | <1.6 |
*Concentration measured in one animal that died 0.5 hour before the end of the exposure period. |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 2 825.69 mg/m³ air
- Quality of whole database:
- Two key read across studies available from structural analogues.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 1984
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well-documented study report equivalent or similar to OECD guideline : GLP
- Justification for type of information:
- A discussion and report on the read across strategy is given as an attachment in IUCLID Section 13.
- Reason / purpose for cross-reference:
- read-across: supporting information
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Hazleton
- Age at study initiation: 19 weeks
- Weight at study initiation: 3.14-3.51
- Housing: individual
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 50 days
ENVIRONMENTAL CONDITIONS
- Temperature (°F): 65-71
- Humidity (%): 40-70
- Photoperiod (hrs dark / hrs light): 12/12
- Details on dermal exposure:
- TEST SITE
- Area of exposure: shoulder region to lumbar region
- Type of wrap if used: gauze and plastic sleeve
REMOVAL OF TEST SUBSTANCE
- Washing (if done): no washing, wiped with gauze
- Time after start of exposure: 24h - Duration of exposure:
- The test material was applied to the skin at the appropriate dose, covered with a gauze patch, secured with tape, and covered with a plastic sleeve. After ca. 24h of exposure, the plastic sleeve, tape and gauze patch were removed. The skin was then wiped (but not washed) with gauze and water to remove any remaining test material.
- Doses:
- The test material was applied to the skin at the appropriate dose, covered with a gauze patch, secured with tape, and covered with a plastic sleeve. After ca. 24h of exposure, the plastic sleeve, tape and gauze patch were removed. The skin was then wiped (but not washed) with gauze and water to remove any remaining test material.
- No. of animals per sex per dose:
- 6 animals/dose (3 males; 3 females)
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:2, 4, 24 hours after dosing and daily for 14 days
- Necropsy of survivors performed: no
- Other examinations performed: clinical signs, body weight - Statistics:
- The means and standard deviations of the body weights were calculated.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- >= 3 160 mg/kg bw
- Mortality:
- none
- Clinical signs:
- other: There was an overall low incidence of clinical in-life observations noted during the study. Observations included nasal discharge, dry rales, alopecia. Topical exposure elicited very slight to well defined erythema in all animals and very slight edema i
- Gross pathology:
- N/A
- Other findings:
- N/A
- Interpretation of results:
- other: Not classified
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The dermal LD50 for MRD-83-349 is greater than 3160 mg/kg. Classification as an acute dermal toxicant is not warranted under the new Regulation (EC) 1272/2008 on classification, labeling and packaging of substances and mixtures (CLP) or under Directive 67/518/EEC for dangerous substances and Directive 1999/45/EC for preparations.
- Executive summary:
The acute dermal toxicity of MRD-83-349 was evaluated in rabbits following topical occlusive exposure. Test material was applied as a single dose of 3160 mg/kg to the clipped backs of 3 male and 3 female rabbits, covered with a gauze patch, and secured with non-irritating tape and a plastic sleeve. The test material remained in contact with the skin for 24 hours. Observations were made as to the nature, onset, severity, and duration of toxicological signs 2, 4, and 24 hours after dosing and once per day thereafter, for a total of 14 days. Dermal responses were evaluated 24 hours after topical application and on Days 3, 7, 10, and 14 according to the Draize method of scoring. Application of MRD-83-349 at a dose level of 3160 mg/kg showed no evidence of systemic toxicity under the conditions of this study and all animals survived to study termination. There were no deaths or treatment-related clinical signs. Topical exposure elicited very slight to well defined erythema in all animals and very slight edema in four animals. Desquamation was noted in five animals during the study. By Day 14, all animals were clear of erythema and edema. Based on the results of this study, the dermal LD50 for MRD-83-349 is greater than 3160 mg/kg.
Classification as an acute dermal toxicant is not warranted under the new Regulation (EC) 1272/2008 on classification, labeling and packaging of substances and mixtures (CLP) or under Directive 67/518/EEC for dangerous substances and Directive 1999/45/EC for preparations.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 3 160 mg/kg bw
- Quality of whole database:
- 1 key read across study available from structural analogues.
Additional information
There is no acute oral or dermal toxicity data available for Undecane. However, data is available for structural analogues, Hydrocarbons, C9-C11, isoalkanes, cyclics, <2% aromatics, Hydrocarbons, C9-C11, cyclics, <2% aromatics, C9 -C13, n-alkanes, and Hydrocarbons, C10-C12, isoalkanes, <2% aromatics. This data is read across to Undecane based on analogue read across and a discussion and report on the read across strategy is provided as an attachment in IUCLID Section 13.
Oral
Hydrocarbons, C10-C12, isoalkanes, <2% aromatics
In a key study (ExxonMobil Corp, 1995), the test material (Hydrocarbons, C10-C12, isoalkanes, <2% aromatics) was administered via oral intubation to 5 male and 5 female rats at a dose of 5000 mg/kg to assess acute oral toxicity. Animals were observed daily for 14 days post dosing. No overt signs of toxicity were apparent. All animals survived to study termination. All animals were free of abnormalities at postmortem examination. All surviving animals displayed increases in body weight over their day 0 values. The acute oral LD50was determined to be >5000 mg/kg.
In another key study (ExxonMobil Corp, 1977), the test material (Hydrocarbons, C10-C12, isoalkanes, <2% aromatics) was evaluated in rats via oral gavage at a dose of 15 g/kg bw. Observations were made as to the nature, onset, severity, and duration of toxicological signs once per day for a total of 14 days. All animals survived the entire observational period and displayed a low incidence of clinical symptoms. The LD50following oral gavage was >15 g/kg.
Hydrocarbons, C9-C11, cyclics, <2% aromatics
In a key study (ExxonMobil Corp., 1988), the test material (Hydrocarbons, C9-C11, cyclics, <2% aromatics) was administered via oral gavage to 5 male and 5 female rats at a dose of 5000 mg/kg to assess acute oral toxicity. Animals were observed daily for 15 days post dosing. At a dose of 5000 mg/kg, signs of toxicity were sedation, dyspnea, hunched posture and ruffled fur. All animals had recovered until day 5 of observation and survived to study termination. All animals were free of abnormalities at postmortem examination. All surviving animals displayed increases in body weight over their day 0 values. The acute oral LD50was determined to be >5000 mg/kg.
Inhalation
Hydrocarbons, C9-C11, isoalkanes, cyclics, <2% aromatics
In a key study (ExxonMobil Corp., 1995) the test material (Hydrocarbons, C9-C11, isoalkanes, cyclics, <2% aromatics) was administered via individual inhalation chambers for four hours to ten Sprague-Dawley rats (5 males, 5 females) to an average actual vapor concentration of 6100 mg/m3for four hours to assess acute inhalation toxicity. Animals were observed for fourteen days following exposure. There were no mortality or gross pathological alterations noted in any of the animals. Based on the conditions of this study, The LC50for acute inhalation exposure was determined to be greater than 6100 mg/m3.
n-alkanes, C9-C13
In a key study (Nilsen OG, Haugen OA, Zahlsen K, Halgunset J, Helseth A, Aarset H, Eide I, 1988) Individual alkanes (n-nonane (n-C9), n-decane (n-C10), n-undecane (n-C11), n-dodecane (n-C12), and n-tridecane (n-C13)) were administered via individual inhalation chambers to eight Sprague-Dawley rats at their respective maximum attainable vapor concentration (n-C9: 5280, 4438, 3560, 2414 ppm; n-C10: 1369 ppm; n-C11: 442 ppm, n-C12; 142 ppm; n-C13: 41 ppm) for eight hours to assess acute inhalation toxicity. There was no mortality and no gross pathological alterations noted in any of the animals treated with n-C10 to n-C13. The LC50after an 8-hour exposure for n-C9 alkane vapors was determined to be 4467 ppm. The LC50after an 8-hour exposure for acute inhalation exposure to n-C10 to n-C13 alkane vapors is greater than the highest obtainable vapor concentration. The LC50after an 8-hour exposure for n-C9 alkane vapors was determined to be 4467 ppm.
Dermal
Hydrocarbons, C9-C11, isoalkanes, cyclics, <2% aromatics
In a key study (ExxonMobil Corp., 1984), the acute dermal toxicity of Hydrocarbons, C9-C11, isoalkanes, cyclics, <2% aromatics was evaluated in rabbits following topical occlusive exposure. Test material was applied as a single dose of 3160 mg/kg to the clipped backs of 3 male and 3 female rabbits, covered with a gauze patch, and secured with non-irritating tape and a plastic sleeve. The test material remained in contact with the skin for 24 hours. Observations were made as to the nature, onset, severity, and duration of toxicological signs 2, 4, and 24 hours after dosing and once per day thereafter, for a total of 14 days. Dermal responses were evaluated 24 hours after topical application and on Days 3, 7, 10, and 14 according to the Draize method of scoring. Application of the test material at a dose level of 3160 mg/kg showed no evidence of systemic toxicity under the conditions of this study and all animals survived to study termination. There were no deaths or treatment-related clinical signs. Topical exposure elicited very slight to well defined erythema in all animals and very slight edema in four animals. Desquamation was noted in five animals during the study. By Day 14, all animals were clear of erythema and edema. Based on the results of this study, the dermal LD50was determined to be greater than 3160 mg/kg.
Justification for classification or non-classification
Based on available read across data, Undecane is minimally toxic via ingestion where the LD50 is >5000 mg/kg, by inhalation where the LC50> 2825.69 mg/m3(maximum attainable vapour concentration of n-C11), and via dermal exposure where the LD50 is >3160 mg/kg. These findings do not warrant classification under the new Regulation (EC) 1272/2008 on classification, labeling and packaging of substances and mixtures (CLP).
Undecane is classified under EU CLP guidelines as a Category 1 aspiration hazard based on its physical and chemical properties (hydrocarbon fluid, viscosity ≤ 20.5 mm2/s).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)